Core Insights - Cannabix Technologies Inc. is participating in a workshop hosted by the U.S. National Institute of Standards and Technology (NIST) focused on cannabis breathalyzer technology [1][2] - The workshop aims to bring together stakeholders from various sectors to discuss advancements in measurement science and standards related to cannabis testing [2] - Cannabix will showcase its Cannabix Marijuana Breath Test (MBT) technology, which detects recent cannabis use by identifying delta-9-tetrahydrocannabinol (Δ9-THC) [3] Company Overview - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath testing technologies for various applications, including workplaces and law enforcement [4] - The company's MBT system utilizes proprietary technologies for breath sample collection and analysis, employing liquid chromatography-mass spectrometry (LC-MS) methods [3][4] - Cannabix is also known for its BreathLogix device aimed at improving alcohol safety and monitoring in organizations [4]

Core Insights - Cannabix Technologies Inc. is participating in a workshop hosted by the U.S. National Institute of Standards and Technology (NIST) focused on cannabis breathalyzer technology [1][2] - The workshop aims to bring together stakeholders from various sectors to discuss advancements in measurement science and standards related to cannabis breath testing [2] - Cannabix will present its Cannabix Marijuana Breath Test (MBT) technology, which detects recent cannabis use by identifying delta-9-tetrahydrocannabinol (Δ9-THC) [3] Company Overview - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath testing devices for workplaces and law enforcement [4] - The company’s technology focuses on detecting recent marijuana use through breath analysis [4] - Cannabix also developed the BreathLogix device for autonomous alcohol screening to enhance safety and monitoring in organizations [4]

Core Insights - Cannabix Technologies Inc. has initiated the phased commercialization of its Cannabix Marijuana Breath Test (MBT) by delivering multiple units to Omega Laboratories in Ohio, focusing on the detection of delta-9-tetrahydrocannabinol (Δ9-THC) in breath samples [1][2] Group 1: Product and Technology - The MBT hardware includes Cannabix's proprietary Breath Collection Unit (BCU) and Breath Cartridges (BC), designed for the recent use detection of Δ9-THC, unlike traditional methods that can detect THC long after consumption [1][2] - The initial shipment consists of 200 Breath Cartridges and several BCUs, supporting the integration of breath testing into Omega's lab testing protocols [2] Group 2: Partnership and Collaboration - Cannabix and Omega are collaborating to implement the MBT with select key clients and are ramping up to meet demand [2] - The partnership includes efforts in manufacturing, marketing, distribution, support, and logistics for the MBT [2] Group 3: Company Background - Omega Laboratories has over twenty years of experience in forensic drug testing and holds multiple federal and international certifications for its facility [3] - Omega's Laboratory Developed Test Method for testing Δ9-THC analytes has been validated in an ISO/IEC 17025 accredited laboratory environment [4]

Group 1 - Cannabix Technologies Inc. has appointed William R. Corl to its board of directors, who is the CEO of Omega Laboratories, a leading drug testing laboratory [1][2] - Cannabix and Omega have been collaborating since May 2024 to commercialize the Marijuana Breath Test (MBT) technology [1][5] - Omega Laboratories has over twenty years of experience in forensic drug testing and holds multiple international certifications [4] Group 2 - Mr. Corl has extensive experience in technology management and has been influential in advancing drug screening regulations [2][3] - The partnership between Cannabix and Omega includes efforts in marketing, distribution, and logistics for the MBT [5] - Cannabix focuses on developing breath testing technologies for recent marijuana use and has also created an alcohol screening device [6]

Core Insights - Cannabix Technologies Inc. has received a notice of allowance for its patent application No. 3243445 for a "Contact-Free Breath Analysis Device and Method" from both the Canadian Intellectual Property Office and the U.S. Patent and Trademark Office, indicating approval for the patent application pending fee payment [1][2]. Group 1: Patent and Technology - The patent application focuses on Cannabix's dual mode contactless and traditional mouthpiece breath capture and analysis technology, which can be integrated into various environments such as vehicles and workplaces, allowing for fast and reliable testing without physical contact [2]. - The technology is designed for unmanned breath devices, providing real-time feedback through visual indicators and displays, making it suitable for law enforcement, workplace safety, and public health monitoring [2]. - The system features intelligent adjustments to its internal airflow and pump mechanisms based on the sampling method, ensuring accurate and hygienic analysis [2]. Group 2: Company Position and Future Developments - The patent application enhances Cannabix's leadership in breath sampling and detection techniques, contributing to the growth of its intellectual capital in breath capture and analytics [3]. - The company plans to report on future material developments regarding its "Contact-Free Breath Analysis Device and Method" patent applications [3]. - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath technologies aimed at workplaces and law enforcement, focusing on recent marijuana use detection [4].

Core Points - Cannabix Technologies Inc. has received a notice of allowance for its patent application regarding a "Contact-Free Breath Analysis Device and Method" from the United States Patent and Trademark Office [1][3] - The technology involves dual mode contactless and traditional mouthpiece breath capture and analysis, applicable in various environments such as vehicles and workplaces, enabling fast and reliable testing without physical contact [2][3] - This patent application enhances Cannabix's position in breath sampling and detection techniques, contributing to its intellectual property portfolio [3] Company Overview - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath testing technologies for workplaces and law enforcement, focusing on recent marijuana use detection [4] - The company has developed the BreathLogix autonomous alcohol screening device aimed at improving alcohol safety and monitoring in organizations [4]